Dalianis T - Search Results

1

ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.

Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH; ECIL-6 Group. Cesaro S, et al. Among authors: dalianis t. J Antimicrob Chemother. 2018 Jan 1;73(1):12-21. doi: 10.1093/jac/dkx324. J Antimicrob Chemother. 2018. PMID: 29190347 Review.

2

Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients.

Dalianis T, Ljungman P. Dalianis T, et al. Anticancer Res. 2011 Mar;31(3):939-44. Anticancer Res. 2011. PMID: 21498717 Review.

3

Human polyomaviruses in disease and cancer.

Dalianis T, Hirsch HH. Dalianis T, et al. Virology. 2013 Mar 15;437(2):63-72. doi: 10.1016/j.virol.2012.12.015. Epub 2013 Jan 26. Virology. 2013. PMID: 23357733 Free article. Review.

4

Management of BK-virus infection - Swedish recommendations.

Dalianis T, Eriksson BM, Felldin M, Friman V, Hammarin AL, Herthelius M, Ljungman P, Mölne J, Wennberg L, Swartling L. Dalianis T, et al. Infect Dis (Lond). 2019 Jul;51(7):479-484. doi: 10.1080/23744235.2019.1595130. Epub 2019 Apr 23. Infect Dis (Lond). 2019. PMID: 31012777

5

Identification of a third human polyomavirus.

Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B. Allander T, et al. Among authors: dalianis t. J Virol. 2007 Apr;81(8):4130-6. doi: 10.1128/JVI.00028-07. Epub 2007 Feb 7. J Virol. 2007. PMID: 17287263 Free PMC article.

6

KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research.

Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL. Dalianis T, et al. Semin Cancer Biol. 2009 Aug;19(4):270-5. doi: 10.1016/j.semcancer.2009.04.001. Epub 2009 May 3. Semin Cancer Biol. 2009. PMID: 19416753 Review.

7

Lessons from immune responses and vaccines against murine polyomavirus infection and polyomavirus-induced tumours potentially useful for studies on human polyomaviruses.

Ramqvist T, Dalianis T. Ramqvist T, et al. Among authors: dalianis t. Anticancer Res. 2010 Feb;30(2):279-84. Anticancer Res. 2010. PMID: 20332429 Review.

8

An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention.

Ramqvist T, Dalianis T. Ramqvist T, et al. Among authors: dalianis t. Anticancer Res. 2011 May;31(5):1515-9. Anticancer Res. 2011. PMID: 21617204 Review.

9

Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.

Franzén AV, Tegerstedt K, Holländerova D, Forstová J, Ramqvist T, Dalianis T. Franzén AV, et al. Among authors: dalianis t. In Vivo. 2005 Mar-Apr;19(2):323-6. In Vivo. 2005. PMID: 15796193 Free article.

10

Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.

Tegerstedt K, Franzén AV, Andreasson K, Joneberg J, Heidari S, Ramqvist T, Dalianis T. Tegerstedt K, et al. Among authors: dalianis t. Anticancer Res. 2005 Jul-Aug;25(4):2601-8. Anticancer Res. 2005. PMID: 16080500 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page